Iratumumab, CAS 640735-09-7

Product Description: Iratumumab (MDX-060) a human anti-CD30 IgG1κ monoclonal antibody. Iratumumab inhibits the growth of CD30-expressing tumor cells. Iratumumab can be used for research of Hodgkin's lymphoma (HL) and anaplastic large-cell lymphoma (ALCL)[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Ansell SM, et al. Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma. J Clin Oncol. 2007 Jul 1;25(19):2764-9.

CAS Number: 640735-09-7

Molecular Weight: N/A

Compound Purity: 98.95

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: TNF Receptor

• SKU: MEXHY-P99669-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99669-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated